Global Hypertension Drugs Market Growth 2023-2029

Global Hypertension Drugs Market Growth 2023-2029


The standard definition of high blood pressure is determined by the Joint National Committee (JNC) on Detection, Evaluation, and Diagnosis of High Blood Pressure. A person is considered to have high blood pressure after three to six elevated blood pressure measurements over several months. These definitions apply to adults who are healthy and not using medication for high blood pressure. If the two pressures fall in different categories, the higher one is used to determine the severity of hypertension.

LPI (LP Information)' newest research report, the “Hypertension Drugs Industry Forecast” looks at past sales and reviews total world Hypertension Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Hypertension Drugs sales for 2023 through 2029. With Hypertension Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hypertension Drugs industry.

This Insight Report provides a comprehensive analysis of the global Hypertension Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hypertension Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Hypertension Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hypertension Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hypertension Drugs.

The global Hypertension Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

With an increase in the population of older people, the market for hypertension drugs has a positive outlook over the forecast period. The prevalence of hypertension is high among the older population with close to 70% of the patients with high BP above the age of 60. Currently, close to 11% of the global population is aged 60 years or over and is estimated to reach nearly 22% by 2050. Since the risk of developing pulmonary hypertension increases with age, a growing older population will aid in the growth prospects of the hypertension drugs market in the coming years.

This report presents a comprehensive overview, market shares, and growth opportunities of Hypertension Drugs market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Calcium Channel Blockers
Diuretics
Beta Blockers Vasodilators
Angiotensin Converting Enzyme Inhibitors
Alpha Blockers
Angiotensin Receptor Blockers
Renin Inhibitors

Segmentation by application
Hospitals
Clinics
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Novartis
Daiichi Sankyo
Actelion Pharmaceuticals
Boehringer Ingelheim
Pfizer

Key Questions Addressed in this Report

What is the 10-year outlook for the global Hypertension Drugs market?

What factors are driving Hypertension Drugs market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Hypertension Drugs market opportunities vary by end market size?

How does Hypertension Drugs break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.


*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Global Hypertension Drugs by Company
4 World Historic Review for Hypertension Drugs by Geographic Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Manufacturing Cost Structure Analysis
11 Marketing, Distributors and Customer
12 World Forecast Review for Hypertension Drugs by Geographic Region
13 Key Players Analysis
14 Research Findings and Conclusion

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings